Dr William Frederick Mccormick I, | |
120 Niles Wheelock Rd, Jonesborough, TN 37659-3306 | |
(423) 348-6012 | |
Not Available |
Full Name | Dr William Frederick Mccormick I |
---|---|
Gender | Male |
Speciality | Pathology - Forensic Pathology |
Location | 120 Niles Wheelock Rd, Jonesborough, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588072177 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZF0201X | Pathology - Forensic Pathology | MD000002622 (Tennessee) | Primary |
207ZF0201X | Pathology - Forensic Pathology | MD0000002622 (Tennessee) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr William Frederick Mccormick I, 120 Niles Wheelock Rd, Jonesborough, TN 37659-3306 Ph: (423) 348-6012 | Dr William Frederick Mccormick I, 120 Niles Wheelock Rd, Jonesborough, TN 37659-3306 Ph: (423) 348-6012 |
News Archive
Cell biologists at the Ruhr-Universit-t Bochum have launched a new project to unravel the role of the enzyme Parkin in promoting neuronal survival. The team of Prof Dr Konstanze F. Winklhofer from the Institute of Physiological Chemistry, Department of Molecular Cell Biology, is looking for new therapeutic options to treat Parkinson's disease. The Michael J. Fox Foundation finances this research project with 125,000 US Dollars.
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
Real-world experience of anti-vascular endothelial growth factor therapy for patients with wet age-related macular degeneration suggests that initial improvements in visual acuity are not maintained over time.
The Fondation du Centre hospitalier de l'Université de Montréal (CHUM) has received a $1.25 million donation from Pfizer Canada for a patient health education program to be set up at CHUM.
From November 14-17, the "2018 Shunde Biomedical Industry Investment Promotion Conference" which ran in parallel with the Precision Medicine and Ion Channel Retreat was successfully held at the Ramada Plaza Hotel, Shunde, Guang Dong, China.
› Verified 9 days ago